Cosmetic Peptides Anti-wrinkle and Firming Everlastide® Plus

Published date: 2025-11-28 14:37:51

Name	Cosmetic Peptides Anti-wrinkle and Firming Everlastide® Plus	CAS#	937286-43-6
Price	$Inquiry/1kg $Inquiry/100kg	Purity	99.0%
Stocking Period	Inquiry	Stock	In Stock
Product Webpage:	https://www.congenpharma.com/Product_detail/100.html

Detail Product Information Product Name:Everlastide® Plus Number: CG-CPT-001 CAS: 937286-43-6 616204-22-9 823202-99-9 305-84-0 INCI: Arginine/Lysine Polypeptide , Acetyl Hexapeptide-8，Dipeptide Diaminobutyroyl Benzylamide Diacetate, Carnosine Specifications: / Appearance: Colorless to pale yellow liquid Solubility: Water-soluble Application: Wrinkle removal or lightening via multi-pathway Patents and Awards: (1) A composition and its application (ZL 201910213751.4) (2) A compound containing a diphenylmethane structure and its application (ZL 201910476362.0) (3) A compound containing a triphenylmethyl structure and its application (ZL 202210080991.3) Manufacturer by CongenPharma. CongenPharma is your trust partner More

Guangzhou Congen Pharmatec Co.,Ltd.

Chemsrc Level: Unverified
Tel: 020-13380081396
Address: Room 206, Building G12, South China Advanced Materials Innovation Park, No. 31 Kefeng Road, Huangpu Dist. Guangzhou,China
Area: China
Contact: Shine Huang
Contact Phone #: 13380081396
Email: marketing@congenpharm.com
Website: https://www.congenpharm.com/
Major Market: Domestic, Southeast Asia, Africa, Europe, South America, North America
Annual Trade Volume:
Foreign Trade % of Sales:
Major partners:

CongenPharma
Founded in 2013 and headquartered in Guangzhou, CongenPharma specializes in pharmaceutical peptide intermediates, cosmetic peptides and ingredients. With our EMPHASES® synthesis platform, we have become a trusted manufacturer in the peptide industry, serving over 500 customers worldwide.

We owned a 2,000+ sqm R&D center and pilot lab with two manufacturing facilities—one fully operational and another under construction. CongenPharma has applied for over 40 patents with 30 granted (USA and Japan) and over 100 trademarks with 74 approved.

Our New LPPS – EMPHASES® Peptide Synthesis Technology uses soluble carriers to replace traditional insoluble solid-phase resin, enabling fast reaction speeds, reduced consumption (amino acids, reagents, and solvents), simplified post-processing and broad applicability. This innovative platform ensures high purity, excellent efficacy and lower-cost peptide synthesis, while supporting green and sustainable peptide synthesis.
Please see website:www.congenpharma.com